Marshall Wace, LLP Mirum Pharmaceuticals, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 175,913 shares of MIRM stock, worth $8.92 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
175,913
Previous 23,722
641.56%
Holding current value
$8.92 Million
Previous $925,000
686.38%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$333 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$232 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$164 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$142 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$132 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.86B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...